AzTrials
AzTrials

Breast Cancer AwarenessNCT07749677

The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees

A study testing Artificial Intelligence Chatbot-Generated Educational Material and Expert-Developed Educational Material in people with Breast Cancer Awareness, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compared two educational approaches for increasing breast cancer awareness among female employees of Eskisehir Odunpazari Municipality. Participants were randomly assigned to receive education using artificial intelligence-generated educational material, education using expert-developed educational… Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Breast Cancer Awareness
What is being tested?
Artificial Intelligence Chatbot-Generated Educational Material and Expert-Developed Educational Material
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteTurkey (Türkiye)
Study dates
11 Mar 2026to 15 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Female employees actively working within Eskişehir Odunpazarı Municipality
  • Aged 18 years or older
  • Literate
  • Having a smartphone to access the digital educational material
  • Agreeing to participate in the study

Who cannot join

  • Previous diagnosis of or treatment for breast cancer
  • Not having a smartphone
  • Being a healthcare professional
  • Not completing the study process

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

  • Eskişehir Odunpazarı Municipality

    Odunpazari, Eskişehir, 26060

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees: A Randomized Controlled Trial

This study compared two educational approaches for increasing breast cancer awareness among female employees of Eskisehir Odunpazari Municipality. Participants were randomly assigned to receive education using artificial intelligence-generated educational material, education using expert-developed educational material, or no educational intervention. Breast cancer awareness was assessed at baseline, immediately after the intervention, and 2 months after the intervention. The study also assessed participants' digital health literacy.

Being tested
Artificial Intelligence Chatbot-Generated Educational Material, Expert-Developed Educational Material
Keywords
Breast cancer awareness, Health education, Digital health literacy, Breast self-examination, Artificial intelligence chatbot
Medical subject headings
Health Education, Breast Self-Examination

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial Intelligence Chatbot-Generated Educational MaterialBehavioural

    A structured educational material was generated using an artificial intelligence chatbot and presented through Google Forms in a conversational question-and-answer format. The content was written in plain language appropriate for female municipal employees aged 18 years or older and covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. Participants accessed the predefined material through a link or QR code. No real-time or personalized chatbot interaction occurred. Both the artificial intelligence chatbot-generated educational material and the expert-developed educational material were evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

  • Expert-Developed Educational MaterialBehavioural

    Breast cancer awareness educational material was developed by the researchers. The material covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. It was evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

Study groups in NCT07749677
Study groupRoleWhat they receive
Artificial Intelligence Chatbot Intervention GroupExperimentalA structured, question-and-answer educational material was generated using an artificial intelligence chatbot. The chatbot was instructed to produce clear, plain-language content appropriate for the health literacy level of female municipal employees aged 18 years or older and to avoid medical terminology. The material covered the definition of breast cancer; risk factors; signs and symptoms; preventive attitudes; barriers to breast cancer screening; breast cancer awareness-related health behaviors; the timing and performance of breast self-examination; findings requiring attention; and breast cancer treatment methods. The content was transferred to Google Forms and presented in a conversational question-and-answer format. Participants accessed the predefined material through a link or QR code and did not interact with a live chatbot or receive real-time, personalized responses.
Receives: Behavioral: Artificial Intelligence Chatbot-Generated Educational Material
Expert Intervention GroupActive comparatorParticipants received breast cancer awareness education using educational material developed by experts in the relevant field. The educational content covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods.
Receives: Behavioral: Expert-Developed Educational Material
Control GroupNo interventionParticipants received no breast cancer awareness education during the study period. They completed the same assessments as the intervention groups at baseline, immediately after the intervention period, and 2 months after the intervention. After completion of the final assessment, participants were provided with breast cancer awareness education.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breast Cancer Awareness Scale Total Score

    Overall breast cancer awareness was assessed using the Breast Cancer Awareness Scale, which consists of five subscales. Total scores range from 0 to 102, with higher scores indicating greater overall breast cancer awareness.

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention.

Secondary outcomes (12)

  1. Factor 1:Knowledge of Risk Factors Score

    Knowledge of breast cancer risk factors was assessed using the Knowledge of Risk Factors subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 18, with higher scores indicating greater knowledge of breast cancer risk factors.

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention

  2. Factor 2: Knowledge of Signs and Symptoms Score

    Knowledge of breast cancer signs and symptoms was assessed using the Knowledge of Signs and Symptoms subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 16, with higher scores indicating greater knowledge of breast cancer signs and symptoms.

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention

  3. Factor 3. Attitudes Toward Breast Cancer Prevention Score

    Attitudes toward breast cancer prevention were assessed using the Attitudes Toward Breast Cancer Prevention subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 24, with higher scores indicating more positive attitudes toward breast cancer prevention

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention

  4. Factor 4. Barriers to Breast Cancer Screening Score

    Perceived barriers to breast cancer screening were assessed using the Barriers to Breast Cancer Screening subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 16. Items are reverse-scored, with higher scores indicating fewer perceived barriers to breast cancer screening.

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention

  5. Factor 5. Health Behaviors Related to Breast Cancer Awareness Score

    Health behaviors related to breast cancer awareness were assessed using the Health Behaviors Related to Breast Cancer Awareness subscale of the Breast Cancer Awareness Scale. Scores range from 0 to 28, with higher scores indicating more positive health behaviors related to breast cancer awareness.

    Measured: Baseline, immediately after the intervention, and 2 months after the intervention

  6. Digital Health Literacy Instrument Total Score

    Overall digital health literacy was assessed using the 18-item Turkish version of the Digital Health Literacy Instrument, which consists of six subscales. The total mean score ranges from 1 to 4, with higher scores indicating greater digital health literacy.

    Measured: Baseline

  7. DHLI Search Score

    Skills related to searching for online health information were assessed using the DHLI Search subscale. Mean scores range from 1 to 4, with higher scores indicating greater information-searching skills.

    Measured: Baseline

  8. DHLI Content Score

    Skills related to adding self-generated content to digital health platforms were assessed using the DHLI Content subscale. Mean scores range from 1 to 4, with higher scores indicating greater content-adding skills.

    Measured: Baseline

  9. DHLI Relevance Score

    Skills related to determining the relevance of online health information were assessed using the DHLI Relevance subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to determine the relevance of online health information.

    Measured: Baseline

  10. DHLI Navigation Score

    Skills related to navigating online health information and digital health environments were assessed using the DHLI Navigation subscale. Mean scores range from 1 to 4, with higher scores indicating greater navigation skills.

    Measured: Baseline

  11. DHLI Privacy Score

    Skills related to protecting personal privacy when using online health resources were assessed using the DHLI Privacy subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to protect personal privacy.

    Measured: Baseline

  12. DHLI Reliability Score

    Skills related to evaluating the reliability of online health information were assessed using the DHLI Reliability subscale. Mean scores range from 1 to 4, with higher scores indicating greater ability to evaluate the reliability of online health information.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2026
  2. Study start11 Mar 2026
  3. Primary completion15 May 2026
  4. Study completion15 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This was a three-arm, parallel-group randomized controlled trial. Participants remained in their assigned group throughout the study.
Masking
Single blind
Who is masked
Participant
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07749677
Sponsor's protocol ID
2026/63
Other IDs
TTU-2026-3999
Status last verified
Aug 2026
First submitted
3 Aug 2026
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because participant consent did not include permission for sharing individual-level data with other researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Artificial Intelligence Chatbot-Generated Educational Material and Expert-Developed Educational Material in people with Breast Cancer Awareness, run by Eskisehir Osmangazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breast Cancer Awareness Scale Total Score (time frame: Baseline, immediately after the intervention, and 2 months after the intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07749677.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in